Brahma Capital
44 Shirley Ave., West Chicago, IL, 60185, United States
Overview
Brahma Capital Inc. provides strategic lending solutions to individuals and small businesses. The company focuses on setting clients up for long-term financial success through various loan products. Services include debt consolidation, cash flow improvement, credit score enhancement, and financing for building and renovation projects. Brahma Capital also offers support for independent mortgage brokers and agents through a dedicated submission process.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- Financial Services
- Lending
- Mortgage
Investment portfolio
- BlossomHill Therapeutics
Led · Series B · Dec 2025
BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, CA that focuses on designing and developing novel targeted medicines for difficult-to-treat cancers. Its science-driven approach addresses specific oncogenic drivers to improve patient outcomes. The company’s two lead clinical assets are BH-30643, a first-in-class, macrocyclic, non-covalent, mutant-selective OMNI-EGFRTM inhibitor aimed at EGFR- or HER2-mutated non-small cell lung cancer, and BH-30236, a macrocyclic CLK inhibitor targeting relapsed or refractory acute myeloid leukemia or higher-risk myelodysplastic syndrome. BlossomHill plans to use fresh capital to accelerate clinical development of these programs and to progress its wholly owned pipeline of designed cancer medicines. Since inception, the company has raised a total of $257 million in equity funding, most recently via a Series B extension. No operating metrics such as revenue or patient enrollment figures were disclosed in the article.
Team
No current team members are available.